SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Brooks Automation
BRKS 96.74+1.4%Apr 13 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: robert b furman who wrote (1098)1/7/2021 1:24:01 AM
From: Johnny Canuck  Read Replies (1) of 1114
 
I am not sure it is a promotion in the sense that BRKS will get more profile.

Small cap indices are for traders who want potential lymore upside due to fact small caps can easily double without needing a huge influx of capital on a relative basis.

If you believe this article ,mid-cap stocks are the unloved uncle that you know exists but does not get much attention.

The drop in share price may simply be the number of shares that need to be add to the index given the outstanding shares of the ETFs is less than what was sold to re-balance the small cap index ETFs. Put another way there were more traders looking for small cap investments related to the index and ETFs as opposed to the mid-cap.

20 best mid-cap stocks for 2021, according to analysts - MarketWatch

Longer term it probably will not matter if the semiconductor equipment sector rises this year as it is predicted to due to new Fabs being built.

I have not have time to research but does BRKS bio-tech division supply equipment to the CRISPR biotech sector. From what I remember of presentations I have seen the value of the CRISPR process is anyone with a little bit of lab knowledge can do the basics. You don't need expensive equipment. What was one of the concerns I saw talked about was unregulated manipulation of DNA can lead to pandemics and other bio-tech related risks as you can essentially do a crude form of gene manipulation in your garage.

If there are more specific equipment requirements for some of the gene related therapies it might be less risky to invest in the people making the equipment than the companies working on individual therapies.

Old saying about being the guy that supplies the gun and ammo instead on being the idealist on either side of the war applies here potentially.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext